Patents by Inventor Brittany Needham

Brittany Needham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROBIOTIC THERAPIES FOR SOCIAL DEFICIT AND STRESS RESPONSE
    Publication number: 20220273732
    Abstract: Some embodiments include bacterial species for use in treatment of social behavioral deficit symptoms in a subject in need thereof. The bacterial species can include Enterococcus faecalis. Upon treatment, one or more symptoms of behavioral deficit can be improved in the subject.
    Type: Application
    Filed: February 24, 2022
    Publication date: September 1, 2022
    Inventors: Sarkis K MAZMANIAN, Wen-Li WU, Mark D ADAME, Brittany NEEDHAM
  • Synthetic lipid biology for combinatorial engineering of endotoxin
    Patent number: 8945587
    Abstract: The present disclosure generally relates to genetic engineering of bacteria. More particularly, the present disclosure relates to genetic engineering of Gram-negative bacteria expressing different species of lipid A on their surface. In one embodiment, the present disclosure provides for an engineered strain of E. coli according to Table 1. In another embodiment, the present disclosure provides for a lipopolysaccharide purified from an engineered strain of E. coli according to Table 1.
    Type: Grant
    Filed: February 28, 2013
    Date of Patent: February 3, 2015
    Assignee: The Board of Regents of The University of Texas System
    Inventors: M. Stephen Trent, Brittany Needham, David Giles, Marvin Whiteley
  • SYNTHETIC LIPID BIOLOGY FOR COMBINATORIAL ENGINEERING OF ENDOTOXIN
    Publication number: 20130230555
    Abstract: The present disclosure generally relates to genetic engineering of bacteria. More particularly, the present disclosure relates to genetic engineering of Gram-negative bacteria expressing different species of lipid A on their surface. In one embodiment, the present disclosure provides for an engineered strain of E. coli according to Table 1. In another embodiment, the present disclosure provides for a lipopolysaccharide purified from an engineered strain of E. coli according to Table 1.
    Type: Application
    Filed: February 28, 2013
    Publication date: September 5, 2013
    Applicant: Board of Regents, The University of Texas System
    Inventors: M. Stephen TRENT, Brittany Needham, David Giles, Marvin Whiteley